Author | Melissa Hardesty, MD | OncLive

Author | Melissa Hardesty, MD

Articles

Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer

August 17, 2018

Video

Melissa Hardesty, MD, gynecologic oncologist, Alaska Women’s Cancer Center, discusses the safety and efficacy of the bevacizumab/PARP inhibitor combination in ovarian cancer.

Dr. Hardesty on Second-Line Maintenance Therapy for Ovarian Cancer

July 17, 2018

Video

Melissa Hardesty, MD, gynecologic oncologist, Alaska Women’s Cancer Center, discusses second-line maintenance therapy after frontline chemotherapy for patients with ovarian cancer.

x